G9190 HCPCS: Reimbursement, Benchmarks & Policy | OpenPayer

Summary & Overview

HCPCS G9190: Documentation of Medical Reason for Not Prescribing Beta-Blocker Therapy

HCPCS Level II code G9190 is used to document medical reasons for not prescribing beta-blocker therapy, such as allergy, intolerance, or other clinical contraindications. This administrative code captures clinician-documented justification when beta-blocker treatment is judged unsafe or inappropriate for a patient. Nationally, precise documentation of medication contraindications affects quality measurement, care coordination, and claims processing across diverse care settings.

Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical purpose and typical sites of service, discussion of common billing modifiers, and the code’s relevance to medication management and quality reporting. The publication highlights benchmark considerations, common billing practices, and policy updates that affect use of documentation codes for medication-related exceptions.

This summary is intended for clinicians, coding professionals, and policy analysts seeking a national perspective on how G9190 is applied in clinical documentation and administrative workflows. Data not available in the input is noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG9190HCPCS Level IIbeta-blockermedication-managementcontraindication-documentationquality-measurementclinical-documentation

Billing Code Overview

HCPCS Level II code G9190 documents the medical reason(s) for not prescribing beta-blocker therapy (for example, allergy, intolerance, or other medical reasons). This code indicates clinical documentation that a patient has a valid medical contraindication or intolerance preventing initiation or continuation of beta-blocker treatment.

Service type: Clinical documentation / medical decision support related to medication management
Typical site of service: Inpatient or outpatient clinical settings where medication decisions are made, including hospital wards, emergency departments, and ambulatory clinics

Clinical & Coding Specifications

Clinical Context

A patient with a history of ischemic heart disease and prior myocardial infarction presents for medication reconciliation and optimization of secondary prevention. The clinician documents that beta-blocker therapy is not prescribed because the patient has documented severe reactive airway disease with repeated bronchospasm on prior beta-blocker exposure and a resting heart rate of 52 beats per minute with symptomatic bradycardia when trials of low-dose beta-blocker were attempted. The clinical workflow includes review of prior medication lists, targeted history for allergy or intolerance, review of recent vital signs and electrocardiogram, documentation of the medical reason(s) for withholding beta-blocker therapy in the medical record, and communication of the rationale to the patient and the primary cardiology team. Typical sites of service include outpatient cardiology clinics, primary care offices, hospital inpatient wards (including cardiology service), and transitional care visits during hospital discharge planning.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when documentation supports unusually extensive medical record review or complex decision-making to justify not prescribing beta-blocker therapy beyond typical counseling time.
`23`

HCPCS G9285: Specimen Site Other Than Lung / Not Classified as NSCLC

HCPCS-G0504-PSYCHIATRIC-COLLABORATIVE-CARE-MANAGEMENT-ADDITIONAL-30MIN

HCPCS G0504: Psychiatric Collaborative Care Management, Additional 30 Minutes

HCPCS-G2083-ESKETAMINE-NASAL-ESTABLISHED-PATIENT-OUTPATIENT-VISIT

HCPCS G2083: Outpatient Visit for Esketamine Nasal Self-Administration

HCPCS-G9321-CT-AND-CARDIAC-NUCLEAR-IMAGING-PRIOR-STUDY-COUNT

HCPCS G9321: Prior CT and Cardiac Nuclear Imaging Study Count

HCPCS-G9217-PCP-PROPHYLAXIS-NOT-PRESCRIBED-CD4-BELOW-200

HCPCS G9217: PCP Prophylaxis Not Prescribed After CD4 <200

HCPCS-G9195-MAJOR-DEPRESSION-NO-ANTIDEPRESSANT-IN-180-DAY-CONTINUATION

HCPCS G9195: Major Depression Without Antidepressant During 180-Day Continuation Phase

HCPCS-G9721-WHEELCHAIR-BOUND-NON-AMBULATORY-STATUS

HCPCS G9721: Non-ambulatory / Wheelchair-Bound Functional Status

HCPCS-G0315-COVID-19-IMMUNIZATION-COUNSELING-UNDER-21-5-15-MINS

HCPCS G0315: COVID-19 Immunization Counseling for Patients Under 21

HCPCS-G9695-LONG-ACTING-INHALED-BRONCHODILATOR-PRESCRIBED

HCPCS G9695: Long-Acting Inhaled Bronchodilator Prescribed

HCPCS-G0042-THERAPY-REFERRAL-PHYSICAL-OCCUPATIONAL-SPEECH-RECREATIONAL

HCPCS G0042: Referral to Physical, Occupational, Speech, or Recreational Therapy

Showing 1–10 of 1996

Taxonomy Code	Specialty	Notes
`207RC0000X`	Cardiology	Cardiology clinicians commonly document rationale for withholding beta-blockers in ischemic heart disease or heart failure.
`207Q00000X`	Interventional Cardiology	Interventional cardiologists may document medication decisions during peri-procedural care.
`208D00000X`	Internal Medicine	Primary care and hospitalists frequently document medication contraindications and intolerances.
`363LP0200X`	Nurse Practitioner	Nurse practitioners in cardiology or primary care often perform medication reconciliation and documentation.
`363A00000X`	Physician Assistant	Physician assistants commonly document clinical reasons for not prescribing beta-blockers in outpatient and inpatient settings.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I50.9`	Heart failure, unspecified	Heart failure is a common indication for beta-blockers; documentation may explain why therapy is withheld due to intolerance or contraindication.
`I21.9`	Acute myocardial infarction, unspecified	Post‑MI patients usually receive beta-blockers; documentation of medical reasons for non-prescribing is relevant in this population.
`J45.909`	Unspecified asthma, uncomplicated	Reactive airway disease can contraindicate nonselective beta-blocker use and is a common reason for withholding therapy.
`R00.1`	Bradycardia, unspecified	Documented bradycardia supports the decision not to initiate or continue beta-blocker therapy.
`T78.40XA`	Allergy, unspecified, initial encounter	Documented allergy to beta-blockers requires notation as the medical reason for not prescribing.
`I48.91`	Unspecified atrial fibrillation	In some arrhythmias beta-blockers are indicated; documentation may explain why they are withheld due to intolerance or other risks.
`N18.9`	Chronic kidney disease, unspecified	Advanced renal dysfunction can influence medication choices and dosing, sometimes leading to withholding beta-blockers.
`E86.0`	Dehydration	Acute volume depletion and hypotension may be reasons to withhold beta-blocker therapy during acute illness.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Common outpatient visit where documentation of medical reason(s) for not prescribing beta-blocker therapy is recorded as part of medication management.
`99223`	Initial hospital care, typically 70 minutes	Inpatient admission encounters where clinicians document medication contraindications during initial evaluation and plan of care.
`99496`	Transitional care management services, high complexity (face-to-face within 7 days of discharge)	Used when documentation of medication decisions, including withholding beta-blockers, occurs during post-discharge transitional care.
`93000`	Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report	Often performed to document bradycardia or conduction abnormalities that support the decision not to prescribe beta-blockers.
`36415`	Collection of venous blood by venipuncture	Laboratory testing to assess electrolytes, renal function, or drug levels that inform the decision to withhold beta-blocker therapy.

OpenPayer